Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis

Journal of the American Academy of Dermatology

Volumn 62, Issue 2, 2010, Pages 315-318

  Shaughnessy, Kerry K ^a   Bouchard, Susan M ^a   Mohr, Melinda R ^a   Herre, John M ^a,b   Salkey, Kimberly S ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Sentara Cardiovascular Research Institute   (United States)

Author keywords

drug reaction; drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome; hypersensitivity syndrome; myocarditis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; DEXAMETHASONE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; MINOCYCLINE; MONTELUKAST; MYCOPHENOLIC ACID; PREDNISONE; QUINAPRIL; RITUXIMAB; TRIAMCINOLONE;

ACNE; ACUTE KIDNEY FAILURE; ADULT; ANAMNESIS; CASE REPORT; CONGESTIVE HEART FAILURE; DESQUAMATION; DRESS SYNDROME; ECHOCARDIOGRAPHY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATURIA; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LYMPHADENOPATHY; MYOCARDITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIORBITAL EDEMA; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN EXAMINATION; THYROIDITIS; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ACNE VULGARIS; ADULT; ANTIBODIES, MONOCLONAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; HUMANS; MINOCYCLINE; MYOCARDITIS; PLASMAPHERESIS;

EID: 73649129930     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.05.046     Document Type: Review

References (21)

1. Ganeva M., Gancheva T., Lazarova R., Troeva J., Baldaranov I., Vassilev I., et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol 47 (2008) 853-860
2. Yun S.J., Lee J.B., Kim E.J., Quan G., Kim S.J., Won Y.H., et al. Drug rash with eosinophilia and systemic symptoms induced by valproate and carbamazepine: formation of circulating auto-antibody against 190-kDa antigen. Acta Derm Venereol 86 (2006) 241-244
3. Allam J.P., Paus T., Reichel C., Bieber T., and Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol 14 (2004) 339-342
4. Lefebvre N., Forestier E., Farhi D., Mahsa M.Z., Remy V., Lesens O., et al. Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: a case report. J Med Case Reports 1 (2007) 22
5. Christe C., Ricou F., Stoller R., and Vogt N. Minocycline-induced pericardial effusion. Ann Pharmacother 34 (2000) 875-877
6. Parneix-Spake A., Bastuji-Garin S., Lobut J.B., Erner J., Guyet-Rousset P., Revuz J., et al. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol 131 (1995) 490-491
7. Roca B., Calvo B., and Ferrer D. Minocycline hypersensitivity reaction with acute respiratory distress syndrome. Intensive Care Med 29 (2003) 338
8. Lee C.W., Mitchell R.N., Horan R.F., and Castells M.C. Cardiogenic shock and peripheral eosinophilia in a young woman. Ann Allergy Asthma Immunol 95 (2005) 229-233
9. Burke A.P., Saenger J., Mullick F., and Virmani R. Hypersensitivity myocarditis. Arch Pathol Lab Med 115 (1991) 764-769
10. Garty B.Z., Offer I., Livni E., and Danon Y.L. Erythema multiforme and hypersensitivity myocarditis caused by ampicillin. Ann Pharmacother 28 (1994) 730-731
11. Colvin J.H., and Sheth A.P. Minocycline hypersensitivity syndrome with hypotension mimicking septic shock. Pediatr Dermatol 18 (2001) 295-298
12. Abe M., Furukawa S., Takayama S., Michitaka K., Minami H., Yamamoto K., et al. Drug-induced hepatitis with autoimmune features during minocycline therapy. Intern Med 42 (2003) 48-52
13. Tsuruta D., Someda Y., Sowa J., Kobayashi H., and Ishii M. Drug hypersensitivity syndrome caused by minocycline. J Cutan Med Surg 10 (2006) 131-135
14. Parc C., Brézin A.P., Nataf I., Dusser D., Moachon L., and D'Hermies F. Presumed hypersensitivity to minocycline and conjunctival infiltration. Br J Ophthalmol 86 (2002) 1313-1314
15. De Bolle L., Naesens L., and De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18 (2005) 217-245
16. Descamps V., Valance A., Edlinger C., Fillet A.M., Grossin M., Lebrun-Vignes B., et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 137 (2001) 301-304
17. Eichenfield A.H. Minocycline and autoimmunity. Curr Opin Pediatr 11 (1999) 447-456
18. Colglazier C.L., and Sutej P.G. Laboratory testing in the rheumatic diseases: a practical review. South Med J 98 (2005) 185-191
19. Maubec E., Wolkenstein P., Loriot M.A., Wechsler J., Mulot C., Beaune P., et al. Minocycline-induced DRESS: evidence for accumulation of the culprit drug. Dermatology 216 (2008) 200-204
20. Muller P., Dubreil P., Mahé A., Lamaury I., Salzer B., Deloumeaux J., et al. Drug Hypersensitivity Syndrome in a West-Indian population. Eur J Dermatol 13 (2003) 478-481
21. Smith K., and Leyden J.J. Safety of doxycycline and minocycline: a systematic review. Clin Ther 27 (2005) 1329-1342